跳至主要内容
临床试验/NCT02488473
NCT02488473已完成2 期

Does Perineural Dexmedetomidine Prolong the Duration of an Adductor Canal Block When Controlling for a Systemic Effect? - A Randomised Paired Trial in Healthy Volunteers.

Zealand University Hospital1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2015年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
21
试验地点
1
主要终点
Difference in duration of sensory block between dexmedetomidine and placebo assessed as cold sensation with an alcohol swab

研究概览

简要总结

Brief Summary: The aim of this trial is to investigate if dexmedetomidine prolongs the duration of an adductor canal block. By using healthy volunteers the investigators can perform a bilateral adductor canal block and thereby control for a systemic effect to clarify if the effect is actually peripheral or systemic. The investigators hypothesis is that dexmedetomidine as an adjunct to a local anaesthetic prolongs the duration of a peripheral nerve block by a peripheral mechanism.

详细描述

Background:

Efficient pain management promoting mobilization and convalescence is essential in an ideal perioperative course. Regional nerve blocks are a central element in postoperative regimes for many patients and it is therefore important that these nerve blocks are both long lasting and efficient. This trial will investigate whether it is possible to optimize the postoperative pain management when adding dexmedetomidine to the local anaesthetic ropivacaine in peripheral nerve blocks.

The prolonging effect of using dexmedetomidine as adjunct in peripheral nerve blocks have been investigated in several studies. However, it remains uncertain whether the effect is mediated by a systemic-, a peripheral- or a combined systemic/peripheral mechanism. In this trial the adjuvating effect of dexmedetomidine will be investigated using the adductor canal block. This is a nerve block that besides being efficient as pain treatment after knee surgery, is primarily sensory, and therefore augments mobilization after total knee arthroplasty.

Method:

On the trial day the volunteers will receive bilateral adductor canal blocks. In one thigh they will receive the local anaesthetic ropivacaine 20ml 5mg/ml and placebo (saline) and in the other thigh ropivacaine 20ml 5mg/ml and dexmedetomidine 100μg. The allocation is blinded to volunteer and investigator.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • American Society of Anesthesiologists class 1
  • Body Mass Index 18-30

排除标准

  • Allergy to study medication
  • Earlier trauma or surgery to lower limb
  • Diabetes Mellitus
  • Alcohol or drug abuse
  • Daily intake of opioids or steroids last 4 weeks
  • Daily intake of any analgesics last 48 hours Heart block Sick sinus node.

研究组 & 干预措施

Ropivacaine + Dexmedetomidine

Experimental

Adductor Canal Block 20 ml Ropivacaine 5mg/ml + 1 ml Dexmedetomidine 100ug/ml

干预措施: Dexmedetomidine (Drug)

Ropivacaine + Dexmedetomidine

Experimental

Adductor Canal Block 20 ml Ropivacaine 5mg/ml + 1 ml Dexmedetomidine 100ug/ml

干预措施: Ropivacaine (Drug)

Ropivacaine + Placebo

Placebo Comparator

Adductor Canal Block 20 ml Ropivacaine 5mg/ml + 1 ml Saline

干预措施: Ropivacaine (Drug)

Ropivacaine + Placebo

Placebo Comparator

Adductor Canal Block 20 ml Ropivacaine 5mg/ml + 1 ml Saline

干预措施: Isotonic Saline (Drug)

结局指标

主要结局

Difference in duration of sensory block between dexmedetomidine and placebo assessed as cold sensation with an alcohol swab

时间窗: 0-36 hours

Duration is defined as time from block performance until recovery of cold sensation to an alcohol swab, assessed every hour post-block (and every half hour when pain scores during the tonic heat stimulation test is above 0) Time for sleep will be provided.

次要结局

  • Difference between dexmedetomidine and placebo in the duration of a sensory block assessed by pin-prick(0-36 hours)
  • Difference between dexmedetomidine and placebo in the duration of a sensory block assessed as maximum pain during a tonic heat stimulation test(0-36 hours)
  • Difference between dexmedetomidine and placebo in the duration of a sensory block assessed as warmth detection threshold(0-36 hours)
  • Difference between dexmedetomidine and placebo in the duration of a sensory block assessed as heat pain detection threshold(0-36 hours)
  • Difference in maximum pain scores between dexmedetomidine and placebo during block and after recovery of normal sensation.(0-36 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jakob Hessel Andersen

Anesthesiologist, Staff Specialist

Zealand University Hospital

研究点 (1)

Loading locations...

相似试验